Ata International Inc recalls Blue Fusion Capsules, 1- count blister pack, Distributed by: DNS Distribution 5225 Canyon Crest Dr. Ste 71-640,
FDA recalls Blue Fusion Capsules due to undeclared ingredients including sildenafil and tadalafil. Consumers should stop using these capsules as they may contain harmful substances without proper approval.
Stop using this now
Marketed Without An Approved NDA/ANDA: FDA analysis found this product to contain undeclared ingredients: Sildenafil, Tadalafil, desmethyl carbodenafil, dithiodesmethyl carbodenafil, scutellarin, and daidzein.
Contact the company & request your remedy
What happened, in plain English
Ata International has recalled Blue Fusion Capsules (1-count blister packs) because they contain undeclared ingredients like sildenafil and tadalafil. This poses a risk of harm since the product was marketed without FDA approval. Read more at govinfonow.com/recall/39089-blue-fusion-capsules-recall-undeclared-ingredients-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/39089-blue-fusion-capsules-recall-undeclared-ingredients-risk · Updated October 5, 2026 · FDA enforcement record: FDA #D-1085-2019
Cite this page
“Blue Fusion Capsules Recall: Undeclared Ingredients Risk.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/39089-blue-fusion-capsules-recall-undeclared-ingredients-risk. Based on FDA recall #D-1085-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1085-2019%22&limit=1).
Why it’s dangerous
The capsules contain undeclared ingredients such as sildenafil, tadalafil, and other substances that were not approved by the FDA. These ingredients can cause serious health risks when taken without proper medical oversight.
Who’s affected
Anyone who owns or uses Blue Fusion Capsules 1-count blister packs distributed by DNS Distribution in Riverside, CA. People with underlying health conditions or those taking other medications are at higher risk.
How to tell if you have this one
Check for Blue Fusion Capsules in 1-count blister packs with the UPC 7 48252 66460 0. The product was distributed by DNS Distribution in Riverside, CA and all lots are affected.
- Brand
Ata International- Product
Blue Fusion Capsules, 1- count blister pack, Distributed by: DNS Distribution 5225 Canyon Crest Dr. Ste 71-640- Category
Drug
What to do — step by step
Stop Using Now
Immediately stop using Blue Fusion Capsules as they contain undeclared ingredients that may cause harm.
Questions people ask
Why were these capsules recalled?
The FDA found that Blue Fusion Capsules contain undeclared ingredients including sildenafil and tadalafil, which were marketed without proper FDA approval.
Are there any specific health risks?
Yes, the undeclared ingredients can cause serious health risks, especially for people with underlying health conditions or those taking other medications.
How can I check if I have the recalled product?
Look for Blue Fusion Capsules in 1-count blister packs with UPC 7 48252 66460 0 distributed by DNS Distribution in Riverside, CA.
Contact Ata International
We’ve drafted a message you can send Ata International to request your refund or repair — edit it as you like.
Subject: Recall D-1085-2019 — Ata International Blue Fusion Capsules, 1- count blister pack, Distributed by: DNS Distribution 522 Hello, I own a Blue Fusion Capsules, 1- count blister pack, Distributed by: DNS Distribution 5225 Canyon Crest Dr. Ste 71-640 that is covered by recall D-1085-2019 from Ata International. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1085-2019 (March 14, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1085-2019 to see it in context.
- Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.